MYRIAD GENETICS INC (MYGN) Form 8-K — Oct 20, 2026
$MYGNForm 8-KItems 1.01, 7.01, 9.01Filed Oct 20, 2026, 8:36 AM ET0000899923-26-000094Original filing
Myriad Genetics has agreed to sell its prenatal health business to Laboratory Corporation of America for $210 million in cash, plus the value of business inventory at closing.
Key figures
- Deal Value Usd
- 210000000
- Outside date
- February 19, 2027, auto-extendable to October 19, 2027
- Reverse termination fee
- $10,500,000 payable by Buyer if regulatory clearances fail in certain circumstances
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.